• Jerry Carter

Latest listings

  • Anti-CD33mAb-DOTA-SH ADC

    Anti-CD33mAb-DOTA-SH ADC

    Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody conjugated via a DOTA-SH linker to a drug. https://www.creative-biolabs.com/adc/target-cd33-11.htm

  • Anti-CD33mAb-DOTA-NCS ADC

    Anti-CD33mAb-DOTA-NCS ADC

    Chemical Methods Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody conjugated via a DOTA-NCS linker to a drug. https://www.creative-biolabs.com/adc/target-cd33-11.htm

  • Anti-CD33mAb-DOTA-G3FC ADC

    Anti-CD33mAb-DOTA-G3FC ADC

    Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody conjugated via a DOTA-G3FC linker to a drug. https://www.creative-biolabs.com/adc/target-cd33-11.htm

  • Anti-CD33 (clone HuM195)-AcBut-Calicheamicin ADC

    Anti-CD33 (clone HuM195)-AcBut-Calicheamicin ADC

    Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody (clone HuM195) conjugated via a AcBut linker to a Calicheamicin. The Calicheamicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor medi...

  • Anti-CD33 (clone h2H12)-Mc-MMAF ADC

    Anti-CD33 (clone h2H12)-Mc-MMAF ADC

    Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody (clone h2H12) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-CD33 (clone m2H12)-Mc-MMAF ADC

    Anti-CD33 (clone m2H12)-Mc-MMAF ADC

    Chemical Methods Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody (clone m2H12) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-CD33 (clone h2H12d)-SGD-1910 ADC

    Anti-CD33 (clone h2H12d)-SGD-1910 ADC

    Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody (cloneh2H12d) conjugated via a linker to SGD-1910. The SGD-1910 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. W...

  • Anti-CD33 (clone hP67.6)-AcBut-calicheamicin ADC

    Anti-CD33 (clone hP67.6)-AcBut-calicheamicin ADC

    Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody (clone hP67.6) conjugated via a AcBut linker to calicheamicin. The calicheamicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediat...

  • Anti-CD33 (clone h2H12) ADC

    Anti-CD33 (clone h2H12) ADC

    Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody (clone h2H12) conjugated via a linker to drug. https://www.creative-biolabs.com/adc/target-cd33-11.htm

  • Anti-CD33 (h2H12ec)-Mc-VC-SGD-1882 ADC

    Anti-CD33 (h2H12ec)-Mc-VC-SGD-1882 ADC

    Drug Development Shirley (New York) August 27, 2019 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody (h2H12ec) conjugated via a Mc-VC linker to SGD-1882. The SGD-1882 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....